TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity

Michael F Kaminski; Laura Bendzick; Rachel Hopps; Marissa Kauffman; Behiye Kodal; Yvette Soignier; Peter Hinderlie; Joshua T Walker; Todd R Lenvik; Melissa A Geller; Jeffrey S Miller; Martin Felices

doi:10.1136/jitc-2022-004725

Article info

PDF

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity

Authors

Michael F Kaminski Hematology, Oncology, and Transplantation, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Laura Bendzick Obstetrics, Gynecology and Women’s Health, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Rachel Hopps Obstetrics, Gynecology and Women’s Health, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Marissa Kauffman Hematology, Oncology, and Transplantation, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Behiye Kodal Hematology, Oncology, and Transplantation, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Yvette Soignier Hematology, Oncology, and Transplantation, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Peter Hinderlie Hematology, Oncology, and Transplantation, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Joshua T Walker Hematology, Oncology, and Transplantation, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Todd R Lenvik Hematology, Oncology, and Transplantation, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Melissa A Geller Obstetrics, Gynecology and Women’s Health, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Jeffrey S Miller Hematology, Oncology, and Transplantation, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles
Martin Felices Hematology, Oncology, and Transplantation, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA PubMed articles Google scholar articles

Citation

Kaminski MF, Bendzick L, Hopps R, et al

TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity

Journal for ImmunoTherapy of Cancer 2022;10:e004725. doi: 10.1136/jitc-2022-004725

Online issue publication

September 26, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password